Mission Wealth Management LP Sells 197 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mission Wealth Management LP decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,271 shares of the medical equipment provider’s stock after selling 197 shares during the period. Mission Wealth Management LP’s holdings in Intuitive Surgical were worth $17,366,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of ISRG. State Street Corp boosted its position in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. FMR LLC boosted its holdings in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after buying an additional 143,440 shares during the last quarter. Fisher Asset Management LLC increased its holdings in Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after buying an additional 86,488 shares during the last quarter. Finally, Baillie Gifford & Co. increased its holdings in Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after buying an additional 24,183 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.7 %

NASDAQ ISRG opened at $573.15 on Monday. The company has a market cap of $204.14 billion, a price-to-earnings ratio of 89.42, a PEG ratio of 5.85 and a beta of 1.39. The company has a 50 day moving average of $569.87 and a 200-day moving average of $529.47. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,077 shares of company stock valued at $4,620,025 in the last three months. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. BTIG Research boosted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Jefferies Financial Group raised their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Royal Bank of Canada lifted their target price on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, Wells Fargo & Company increased their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.